Skip to Main Content

Author Details

Wei Shao
Inc., Frederick National Laboratory for Cancer Research
1993
74
36
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37252967HIV-1 usurps transcription start site heterogeneity of host RNA polymerase II to maximize replication fitness.Proc Natl Acad Sci U S A2023
33946976CpG Methylation Profiles of HIV-1 Pro-Viral DNA in Individuals on ART.Viruses2021
33826675Integration in oncogenes plays only a minor role in determining the in vivo distribution of HIV integration sites before or during suppressive antiretroviral therapy.PLoS Pathog2021
33832973Early Emergence and Long-Term Persistence of HIV-Infected T-Cell Clones in Children.mBio2021
341279802020 SARS-CoV-2 diversification in the United States: Establishing a pre-vaccination baseline.medRxiv2021
34176496HIVIntact: a python-based tool for HIV-1 genome intactness inference.Retrovirology2021
31502467HIV Proviral Sequence Database: A New Public Database for Near Full-Length HIV Proviral Sequences and Their Meta-Analyses.AIDS Res Hum Retroviruses2020
31723024Impact of Antiretroviral Therapy Duration on HIV-1 Infection of T Cells within Anatomic Sites.J Virol2020
31776265Intact HIV Proviruses Persist in Children Seven to Nine Years after Initiation of Antiretroviral Therapy in the First Year of Life.J Virol2020
32683881Short Communication: HIV-DRLink: A Tool for Reporting Linked HIV-1 Drug Resistance Mutations in Large Single-Genome Data Sets Using the Stanford HIV Database.AIDS Res Hum Retroviruses2020
33016926HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virus.J Clin Invest2020
32727364Correction to: An analytical pipeline for identifying and mapping the integration sites of HIV and other retroviruses.BMC Genomics2020
32151239An analytical pipeline for identifying and mapping the integration sites of HIV and other retroviruses.BMC Genomics2020
31361603HIV-1 in lymph nodes is maintained by cellular proliferation during antiretroviral therapy.J Clin Invest2019
31776247Combined HIV-1 sequence and integration site analysis informs viral dynamics and allows reconstruction of replicating viral ancestors.Proc Natl Acad Sci U S A2019
31611857Memory CD4 + T-Cells Expressing HLA-DR Contribute to HIV Persistence During Prolonged Antiretroviral Therapy.Front Microbiol2019
31471273HIV Rebound Is Predominantly Fueled by Genetically Identical Viral Expansions from Diverse Reservoirs.Cell Host Microbe2019
31579817No evidence of ongoing HIV replication or compartmentalization in tissues during combination antiretroviral therapy: Implications for HIV eradication.Sci Adv2019
31487271Linked dual-class HIV resistance mutations are associated with treatment failure.JCI Insight2019
31632364HIV Infected T Cells Can Proliferate <i>in vivo</i> Without Inducing Expression of the Integrated Provirus.Front Microbiol2019
29370196Lower pre-ART intra-participant HIV-1 pol diversity may not be associated with virologic failure in adults.PLoS One2018
29936863Early Presence of HIV-1 Subtype C in Washington, D.C.AIDS Res Hum Retroviruses2018
29463681Bromodomain-containing protein 4-independent transcriptional activation by autoimmune regulator (AIRE) and NF-κB.J Biol Chem2018
29762162Genetic characterization of the HIV-1 reservoir after Vacc-4x and romidepsin therapy in HIV-1-infected individuals.AIDS2018
28891813No evidence of HIV replication in children on antiretroviral therapy.J Clin Invest2017
30310821Ongoing HIV Replication During ART Reconsidered.Open Forum Infect Dis2017
28225830Ex vivo activation of CD4+ T-cells from donors on suppressive ART can lead to sustained production of infectious HIV-1 from a subset of infected cells.PLoS Pathog2017
28331090Hili Inhibits HIV Replication in Activated T Cells.J Virol2017
28272134Romidepsin-induced HIV-1 viremia during effective antiretroviral therapy contains identical viral sequences with few deleterious mutations.AIDS2017
28328934Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir.PLoS Pathog2017
28416661Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART.Proc Natl Acad Sci U S A2017
28845251A5â¿¿Peripheral blood cells contribute to HIV-1 viremia induced by romidepsin.Virus Evol2017
26858442Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo.Proc Natl Acad Sci U S A2016
27605062Broad activation of latent HIV-1 in vivo.Nat Commun2016
27998286Ultrasensitive single-genome sequencing: accurate, targeted, next generation sequencing of HIV-1 RNA.Retrovirology2016
27365398FBXO3 Protein Promotes Ubiquitylation and Transcriptional Activity of AIRE (Autoimmune Regulator).J Biol Chem2016
27439715APOBEC3 proteins can copackage and comutate HIV-1 genomes.Nucleic Acids Res2016
27377064Retrovirus Integration Database (RID): a public database for retroviral insertion sites into host genomes.Retrovirology2016
25384976Cyclin-dependent kinase 12 increases 3' end processing of growth factor-induced c-FOS transcripts.Mol Cell Biol2015
26302493A Population-Structured HIV Epidemic in Israel: Roles of Risk and Ethnicity.PLoS One2015
26559632Well-mixed plasma and tissue viral populations in RT-SHIV-infected macaques implies a lack of viral replication in the tissues during antiretroviral therapy.Retrovirology2015
26581989Origin of Rebound Plasma HIV Includes Cells with Identical Proviruses That Are Transcriptionally Active before Stopping of Antiretroviral Therapy.J Virol2015
25712966Longitudinal Genetic Characterization Reveals That Cell Proliferation Maintains a Persistent HIV Type 1 DNA Pool During Effective HIV Therapy.J Infect Dis2015
24338353An example of genetically distinct HIV type 1 variants in cerebrospinal fluid and plasma during suppressive therapy.J Infect Dis2014
24968937HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells.Science2014
24760888Mutations in HIV-1 reverse transcriptase affect the errors made in a single cycle of viral replication.J Virol2014
24681054PAPNC, a novel method to calculate nucleotide diversity from large scale next generation sequencing data.J Virol Methods2014
24651464Lack of detectable HIV-1 molecular evolution during suppressive antiretroviral therapy.PLoS Pathog2014
23583545Evaluation of sequence ambiguities of the HIV-1 pol gene as a method to identify recent HIV-1 infection in transmitted drug resistance surveys.Infect Genet Evol2013
24277811The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time.Proc Natl Acad Sci U S A2013
  • 1 - 50 of 74

Recommended Authors

Thiago Y Oliveira
The Rockefeller University
Career Start Year 2010
Number of shared co-authors 1
Shuntai Zhou
University of North Carolina at Chapel Hill
Career Start Year 2010
Number of shared co-authors 2
Tian-Hao Zhang
David Geffen School of Medicine, University of California los angeles
Career Start Year 2009
Number of shared co-authors 2
Judd F Hultquist
Northwestern University Feinberg School of Medicine
Career Start Year 2008
Number of shared co-authors 6
Will Dampier
Drexel University College of Medicine
Career Start Year 2007
Number of shared co-authors 0
Max W Chang
University of California San Diego
Career Start Year 2007
Number of shared co-authors 2
Kristen K Dang
Benaroya Research Institute at Virginia Mason
Career Start Year 2006
Number of shared co-authors 1
Fabio Zanini
Stanford University
Career Start Year 2006
Number of shared co-authors 1
Lara Manganaro
National Institute of Molecular Genetics, "Fondazione Romeo ed Enrica Invernizzi"
Career Start Year 2005
Number of shared co-authors 1
Pavitra Roychoudhury
Fred Hutchinson Cancer Center
Career Start Year 2004
Number of shared co-authors 1
Davey M Smith
University of California San Diego
Career Start Year 2001
Number of shared co-authors 5
Jacques Fellay
Ecole Polytechnique Federale de Lausanne
Career Start Year 2001
Number of shared co-authors 4
Tracy L Diamond
Merck & Co. Inc.
Career Start Year 2001
Number of shared co-authors 1
Satish K Pillai
Vitalant Research Institute, USA University of California san francisco
Career Start Year 2001
Number of shared co-authors 5
Edward P Browne
University of North Carolina at Chapel Hill
Career Start Year 2000
Number of shared co-authors 1
Renate K??nig
Paul-Ehrlich-Institut
Career Start Year 1998
Number of shared co-authors 2
Viviana Simon
Icahn School of Medicine at Mount Sinai
Career Start Year 1997
Number of shared co-authors 2
Paul D Bieniasz
The Rockefeller University
Career Start Year 1993
Number of shared co-authors 2
Lubbertus C F Mulder
Icahn School of Medicine at Mount Sinai
Career Start Year 1993
Number of shared co-authors 2
Roger Paredes
Hospital Germans Trias i Pujol
Career Start Year 1992
Number of shared co-authors 7
Keith R Jerome
Fred Hutchinson Cancer Center
Career Start Year 1991
Number of shared co-authors 2
Pavel Sova
Altius Institute for Biomedical Sciences
Career Start Year 1990
Number of shared co-authors 0
Mohan Somasundaran
University of Massachusetts Chan Medical School
Career Start Year 1985
Number of shared co-authors 2
Frederic D Bushman
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1983
Number of shared co-authors 5
Michael Emerman
Fred Hutchinson Cancer Center
Career Start Year 1982
Number of shared co-authors 3
Daniel R Kuritzkes
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1979
Number of shared co-authors 5
Steven M Wolinsky
Northwestern University Feinberg School of Medicine
Career Start Year 1979
Number of shared co-authors 7
Robert F Siliciano
Johns Hopkins University School of Medicine
Career Start Year 1978
Number of shared co-authors 7
Amalio Telenti
Vir Biotechnology Inc.
Career Start Year 1977
Number of shared co-authors 4
Douglas D Richman
Center for AIDS Research, University of California San Diego
Career Start Year 1970
Number of shared co-authors 7

Collaborators

Xiaolin Wu
Leidos Biomedical Research Inc.
Co-authored papers 10
Brandon F Keele
Co-authored papers 8
Steven G Deeks
University of California san francisco
Co-authored papers 7
Zandrea Ambrose
Co-authored papers 5
Peter Bacchetti
University of California San Francisco
Co-authored papers 5
Frederick M Hecht
Co-authored papers 5
Elizabeth Sinclair
Co-authored papers 4
Koh Fujinaga
University of California at San Francisco
Co-authored papers 4
Boris Matija Peterlin
University of California at San Francisco
Co-authored papers 4
Philippe Lemey
Rega Institute, Laboratory of Clinical and Evolutionary Virology
Co-authored papers 4
Peter W Hunt
Co-authored papers 3
Maudi Killian
University of California San Francisco
Co-authored papers 3
Robert M Stephens
Frederick National Laboratory for Cancer Research, Inc.
Co-authored papers 3
Jeffrey D Lifson
Frederick National Laboratory
Co-authored papers 3
Joseph B Margolick
Johns Hopkins Bloomberg School of Public Health
Co-authored papers 2
Ronald Swanstrom
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Co-authored papers 2
Tristan Eifler
University of California at San Francisco
Co-authored papers 1
Jeffrey R Johnson
Gladstone Institutes
Co-authored papers 1
Stefanie J??ger
Institute of Molecular Biosciences, Goethe University Frankfurt
Co-authored papers 1
Kei Sato
The Institute of Medical Science, The University of Tokyo
Co-authored papers 1
Richard T Davey
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 1
Karen Byth
Westmead Hospital
Co-authored papers 1
Koen Bartholomeeusen
Institute of Tropical Medicine
Co-authored papers 1
Rajesh T Gandhi
Co-authored papers 1
Rafael Delgado
Instituto de Investigacion Hospital 12 de Octubre (imas12)
Co-authored papers 1
Jos?? R Arribas
La Paz University Hospital
Co-authored papers 1
Daniele C Cary
University of California san francisco
Co-authored papers 1
Michael M Lederman
Co-authored papers 1
Judith S Currier
David Geffen School of Medicine, University of California los angeles
Co-authored papers 1
Richard Haubrich
Co-authored papers 1
Release 1.2